Romark Alinia Tab. Approval Expected First Half 2004; AIDS Claim To Follow
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Romark expects approval in the first half of 2004 for a tablet formulation of its antimicrobial Alinia for use in immunocompetent adults and adolescents with diarrhea associated with Giardia lamblia and Cryptosporidium parvum.